Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
The American Journal of Pathology|April 1, 1992
Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemiaM Schumer, M C Colombel, I S Sawczuk, et al.
The Urologic Clinics of North America|November 1, 1996
The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomyA E Katz, G M de Vries, M C Benson, et al.
Cancer Research|June 15, 1997
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinomaJ M McKiernan, R Buttyan, N H Bander, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patientsN Lee, R Fawaaz, C A Olsson, et al.
The Journal of Urology|May 1, 1996
Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomyC A Olsson, G M de Vries, A J Raffo, et al.
Translational Psychiatry|September 17, 2014
Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective studyK Little, C A Olsson, S Whittle, et al.
Urology|September 4, 1999
Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patientsN Lee, J H Newhouse, C A Olsson, et al.
American Journal of Clinical Pathology|April 13, 2000
Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31A de la Taille, A E Katz, E Bagiella, et al.
The Journal of Urology|June 24, 1999
Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?A de la Taille, M A Rubin, E Bagiella, et al.
International Journal of Cancer|July 15, 1999
Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomyA de la Taille, C A Olsson, R Buttyan, et al.
Pageof 20